Samir J. Patel

409 total citations
21 papers, 285 citations indexed

About

Samir J. Patel is a scholar working on Transplantation, Infectious Diseases and Nephrology. According to data from OpenAlex, Samir J. Patel has authored 21 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Transplantation, 8 papers in Infectious Diseases and 7 papers in Nephrology. Recurrent topics in Samir J. Patel's work include Renal Transplantation Outcomes and Treatments (12 papers), Renal Diseases and Glomerulopathies (6 papers) and Polyomavirus and related diseases (5 papers). Samir J. Patel is often cited by papers focused on Renal Transplantation Outcomes and Treatments (12 papers), Renal Diseases and Glomerulopathies (6 papers) and Polyomavirus and related diseases (5 papers). Samir J. Patel collaborates with scholars based in United States and India. Samir J. Patel's co-authors include A. Osama Gaber, Richard J. Knight, Linda W. Moore, J. DeVos, Lillian W. Gaber, Edward A. Graviss, Larry D. Teeter, Geoffrey A. Land, Duc T. Nguyen and William L. Musick and has published in prestigious journals such as SHILAP Revista de lepidopterología, Transplantation and American Journal of Transplantation.

In The Last Decade

Samir J. Patel

21 papers receiving 283 citations

Peers

Samir J. Patel
Robert Naraghi United States
A Lo United States
Sarat Kuppachi United States
Timothy A. Horwedel United States
Shehzad Rehman United States
Harish Mahanty United States
S. Mehta India
Robert Naraghi United States
Samir J. Patel
Citations per year, relative to Samir J. Patel Samir J. Patel (= 1×) peers Robert Naraghi

Countries citing papers authored by Samir J. Patel

Since Specialization
Citations

This map shows the geographic impact of Samir J. Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir J. Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir J. Patel more than expected).

Fields of papers citing papers by Samir J. Patel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samir J. Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir J. Patel. The network helps show where Samir J. Patel may publish in the future.

Co-authorship network of co-authors of Samir J. Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Samir J. Patel. A scholar is included among the top collaborators of Samir J. Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samir J. Patel. Samir J. Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Samir J., et al.. (2024). Prevalence and Management of Premenstrual Dysphoric Disorder (PMDD): Literature Review. RESEARCH REVIEW International Journal of Multidisciplinary. 9(6). 316–321. 1 indexed citations
2.
Knight, Richard J., Duc T. Nguyen, Edward A. Graviss, et al.. (2021). Long-Term Follow-Up of Renal Transplant Recipients Treated With IVIG for De Novo Donor-Specific Antibodies. Transplantation Proceedings. 53(6). 1865–1871. 1 indexed citations
3.
Patel, Samir J., et al.. (2020). Clinical Outcomes Following Tocilizumab Administration in Mechanically Ventilated Coronavirus Disease 2019 Patients. Critical Care Explorations. 2(10). e0232–e0232. 6 indexed citations
4.
Patel, Samir J., Richard J. Knight, Edward A. Graviss, et al.. (2019). Ciprofloxacin for BK viremia prophylaxis in kidney transplant recipients: Results of a prospective, double-blind, randomized, placebo-controlled trial. American Journal of Transplantation. 19(6). 1831–1837. 16 indexed citations
5.
Knight, Richard J., Edward A. Graviss, Duc T. Nguyen, et al.. (2018). Conversion from tacrolimus‐mycophenolate mofetil to tacrolimus‐mTOR immunosuppression after kidney‐pancreas transplantation reduces the incidence of both BK and CMV viremia. Clinical Transplantation. 32(6). e13265–e13265. 12 indexed citations
6.
Knight, Richard J., Todd N. Eagar, Duc T. Nguyen, et al.. (2018). De Novo DSA in the Setting of Stable Renal Allograft Function is a Benign Finding. Transplantation. 102(Supplement 7). S39–S39. 1 indexed citations
7.
Eagar, Todd N., A. Osama Gaber, Samir J. Patel, et al.. (2017). The detrimental impact of persistent vs an isolated occurrence of de novo donor‐specific antibodies on intermediate‐term renal transplant outcomes. Clinical Transplantation. 31(8). 1 indexed citations
8.
Patel, Samir J., et al.. (2017). Belatacept conversion in an HIV‐positive kidney transplant recipient following anti‐thymocyte globulin induction. Transplant Infectious Disease. 19(5). 3 indexed citations
9.
Knight, Richard J., Wesley A. Mayer, Samir J. Patel, et al.. (2016). Intermediate-Term Outcomes of Dual Adult versus Single-Kidney Transplantation: Evolution of a Surgical Technique. SHILAP Revista de lepidopterología. 2016. 1–6. 5 indexed citations
10.
Patel, Samir J., et al.. (2016). Combination Drug Products for HIV–A Word of Caution for the Transplant Clinician. American Journal of Transplantation. 16(8). 2479–2482. 18 indexed citations
11.
Patel, Samir J., Wadi N. Suki, Edward A. Graviss, et al.. (2016). Disparate rates of acute rejection and donor-specific antibodies among high-immunologic risk renal transplant subgroups receiving antithymocyte globulin induction. Transplant International. 29(8). 897–908. 5 indexed citations
12.
Patel, Samir J., et al.. (2016). Incidence and Factors Associated with De Novo DSA After BK Viremia in Renal Transplant Recipients.. PubMed. 32. 103–109. 11 indexed citations
13.
Knight, Richard J., Larry D. Teeter, Edward A. Graviss, et al.. (2014). Barriers to Preemptive Renal Transplantation. Transplantation. 99(3). 576–579. 19 indexed citations
14.
DeVos, J., A. Osama Gaber, Samir J. Patel, et al.. (2014). Treatment of De Novo Donor Specific Antibodies After Renal Transplant With IVIG.. Transplantation. 98. 138–138. 1 indexed citations
15.
Patel, Samir J., et al.. (2014). Observations on the use of cidofovir for BK virus infection in renal transplantation. Transplant Infectious Disease. 16(6). 975–983. 34 indexed citations
16.
Knight, Richard J., Lillian W. Gaber, Samir J. Patel, et al.. (2013). Screening for BK Viremia Reduces But Does Not Eliminate the Risk of BK Nephropathy. Transplantation. 95(7). 949–954. 35 indexed citations
17.
DeVos, J., A. Osama Gaber, Larry D. Teeter, et al.. (2013). Intermediate-Term Graft Loss After Renal Transplantation is Associated With Both Donor-Specific Antibody and Acute Rejection. Transplantation. 97(5). 534–540. 60 indexed citations
18.
Knight, Richard J., J. DeVos, Samir J. Patel, et al.. (2013). Outcomes of Living Donor Renal Transplants With a Negative Cross-Match and Pretransplant Donor-Specific Antibody. Transplantation Proceedings. 45(4). 1399–1401. 3 indexed citations
19.
Gainer, Sarah M., Samir J. Patel, Harish Seethamraju, et al.. (2011). Increased mortality of solid organ transplant recipients with H1N1 infection: a single center experience. Clinical Transplantation. 26(2). 229–237. 14 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026